Researchers are discovering that a group of popular medications originally developed for diabetes may offer benefits that go far beyond blood sugar control and weight loss.
A new study suggests that these medicines could also help reduce the likelihood of knee replacement surgery in people with osteoarthritis, one of the most common causes of pain and disability worldwide.
Osteoarthritis is a long-term condition that occurs when the protective cartilage that cushions the ends of bones gradually breaks down. As the cartilage wears away, bones begin rubbing against each other, leading to pain, stiffness, swelling, and difficulty moving.
The condition most often affects the knees, hips, hands, and spine. It becomes more common with age and is especially widespread among people who are overweight or obese because excess body weight places additional stress on joints.
Today, more than 300 million people around the world are estimated to have osteoarthritis. Despite its enormous impact, there are currently no medications that can reliably stop or reverse the disease.
Most treatments focus on relieving symptoms through pain medications, exercise, physical therapy, weight management, and, in severe cases, joint replacement surgery.
Because of the growing burden of osteoarthritis, researchers are actively searching for new approaches that could slow disease progression. One area attracting increasing attention involves GLP-1 receptor agonists, a class of medications that includes semaglutide and tirzepatide.
These drugs have become widely known because they help people lose weight and improve blood sugar control. However, scientists have also found evidence that they may reduce inflammation and possibly protect joint tissues.
To investigate this possibility, researchers analyzed anonymized medical records from the TriNetX Global Research Network. Their findings were published in the journal Regional Anesthesia & Pain Medicine. The study included adults diagnosed with knee osteoarthritis between 2010 and 2024.
The researchers compared patients who received GLP-1 receptor agonists with similar patients who did not receive these medications. They examined different treatment durations and looked separately at newer-generation drugs such as semaglutide and tirzepatide.
The results were encouraging. Patients who used GLP-1 receptor agonists were consistently less likely to undergo total knee replacement surgery. The protective effect appeared at multiple follow-up periods and became stronger over time. The greatest benefit was seen among people who used newer medications for longer periods.
For example, patients who received semaglutide or tirzepatide for three years had a substantially lower risk of needing knee replacement surgery even eight years later. The reduction was nearly five percentage points compared with similar patients who did not receive these medications.
Researchers believe several factors may explain the findings. Weight loss itself reduces pressure on knee joints, which may slow joint damage.
In addition, laboratory studies suggest these medications may reduce inflammation and influence biological processes within joint tissues. Some previous research has also found that they may reduce pain associated with osteoarthritis.
The investigators emphasized that this study does not prove the drugs directly prevent surgery. Because it was an observational study based on medical records, other factors may have influenced the results.
Information about physical activity levels, disease severity, and other health characteristics was not fully available. Furthermore, prescription records cannot guarantee that patients actually took the medications.
Nevertheless, the findings are important because they involve large numbers of patients treated in real-world settings rather than highly selected clinical trial participants. The study raises the possibility that managing metabolic health could become an important part of preserving joint health.
If you care about pain, please read studies about how to manage your back pain, and Krill oil could improve muscle health in older people.
For more health information, please see recent studies about how to live pain-free with arthritis, and results showing common native American plant may help reduce diarrhea and pain.
Source: TriNetX Global Research Network.
